Quick answer: Vitamin C is not simply “good for immunity” — it is required for 8 specific enzymatic reactions including collagen synthesis, norepinephrine production, and carnitine biosynthesis. The RDA of 75–90 mg/day is calibrated to prevent scurvy, not optimize function. For immune support, 500–1,000 mg/day reduces cold duration by 8% in adults and 14% in children; for tissue repair, collagen synthesis, and stress response, 1,000–2,000 mg/day via liposomal or divided-dose delivery is optimal. High-dose IV vitamin C (25–75 g) remains investigational for cancer support and sepsis.
Vitamin C Is Not Just an Antioxidant
Vitamin C (L-ascorbic acid) is often categorized as an antioxidant — which is accurate but incomplete. It is more precisely an electron donor that serves as a cofactor for multiple enzyme classes. The 8 vitamin C-dependent enzymes include: prolyl and lysyl hydroxylases (required for collagen triple-helix stabilization), dopamine beta-monooxygenase (required for norepinephrine and epinephrine synthesis), peptidylglycine alpha-amidating monooxygenase (required for activating numerous neuropeptides), and multiple dioxygenases involved in fatty acid metabolism and gene expression regulation via HIF-1α hydroxylation.
The collagen connection is particularly important for understanding why vitamin C deficiency manifests as scurvy: without adequate ascorbate, collagen triple helices cannot properly stabilize (proline and lysine residues fail to hydroxylate), producing structurally weak connective tissue that fails at the highest-stress points first — gingival bleeding, capillary fragility, wound failure, perifollicular hemorrhage. These are connective tissue failure manifestations, not antioxidant deficiency manifestations per se.
The gene regulation mechanism is newer and potentially significant for longevity: vitamin C is a cofactor for TET methylcytosine dioxygenases — the enzymes that catalyze DNA demethylation. Adequate vitamin C status is therefore required for normal epigenetic programming and may explain some of the cancer-preventive associations seen in epidemiological studies.
Vitamin C and the Immune System: Specific Mechanisms
Vitamin C accumulates in immune cells at concentrations 50–100 times higher than plasma levels — a physiological gradient that requires active uptake via SVCT (sodium-dependent vitamin C transporter) proteins. This concentration pattern reflects specific immune cell functions:
Neutrophil function: Neutrophils are the first responders to infection and use vitamin C to fuel the “oxidative burst” — the release of reactive oxygen species (superoxide, hypochlorous acid) used to kill pathogens. Vitamin C then protects neutrophils from auto-oxidative damage during this process, extending their functional lifespan. After the oxidative burst, vitamin C promotes neutrophil apoptosis (programmed death) and their clearance by macrophages — resolving inflammation rather than allowing necrotic neutrophil accumulation that perpetuates tissue damage.
T and B lymphocyte proliferation: Vitamin C is required for lymphocyte differentiation and proliferation in response to antigen. Deficiency reduces natural killer (NK) cell activity — the innate immune cells that identify and kill virus-infected and cancer cells without prior sensitization. A single night of sleep deprivation reduces NK cell activity by 70%; vitamin C status is a second major modulator of the same cells.
Interferon production: Vitamin C stimulates interferon-alpha and interferon-beta production — the antiviral signaling proteins that prevent viral spread between cells. This mechanism may partially explain the observed reductions in cold duration with vitamin C supplementation.
Cortisol and the adrenal connection: The adrenal glands have the highest vitamin C concentration of any tissue in the body — up to 3,000 mcg/g, compared to approximately 5 mcg/ml in plasma. Cortisol synthesis requires vitamin C as a cofactor, and acute stress causes rapid depletion of adrenal ascorbate stores. This creates a feedback loop: chronic stress increases vitamin C utilization, which can deplete stores, impairing both the stress response and the immune function that depends on adequate vitamin C.
The Common Cold Evidence: What the Cochrane Review Actually Says
The Cochrane Review on vitamin C and the common cold (Hemila & Chalker, most recent update 2013, including 29 comparison trials, n=11,306) is the most cited evidence base and is frequently misrepresented. The nuanced findings:
Prevention (regular supplementation in the general population): Regular vitamin C supplementation (200 mg+ daily) does NOT significantly reduce cold incidence in the general population — the relative risk for getting a cold was not significantly reduced. This is the most commonly cited finding, and it is used to dismiss vitamin C for immune support.
Prevention in people under high physical stress: In people exposed to extreme physical stress — marathon runners, skiers, military personnel — regular vitamin C supplementation reduced cold incidence by approximately 50%. This is a large effect and suggests that vitamin C prevents stress-induced immune suppression specifically.
Duration of colds with regular supplementation: Regular daily vitamin C supplementation reduced cold duration by 8% in adults and 14% in children. This is statistically significant, consistent across studies, and clinically meaningful at population scale — even if modest for the individual.
Therapeutic use (starting at cold onset): In a subset of trials testing high-dose vitamin C started at the first sign of cold symptoms, there was insufficient evidence to draw firm conclusions, though individual trials showed reductions in severity and duration. The FLAVIOLA trial (1,000 mg vitamin C at cold onset, published 2021) found significant reduction in cold severity scores.
The practical takeaway: 500–1,000 mg/day regular supplementation is evidence-supported for reducing cold duration, not just as a therapeutic intervention. The “take vitamin C only when sick” approach is less well-supported than baseline supplementation for consistent immune optimization.
Collagen Synthesis: The Aesthetic and Structural Applications
Vitamin C is essential for collagen production — not as a direct building block but as the enzymatic cofactor that makes collagen structurally functional. Prolyl 4-hydroxylase and lysyl hydroxylase require ascorbate as an electron donor; without it, collagen procollagen chains cannot form proper cross-links and the triple helix structure is unstable. This matters for:
Skin aging: Collagen comprises approximately 75% of the dry weight of skin dermis. Skin vitamin C concentrations decline with age and with UV exposure (UV radiation rapidly depletes epidermal ascorbate). Topical vitamin C (10–20% L-ascorbic acid, properly formulated at pH 2.5–3.5) penetrates the epidermis and delivers ascorbate directly to dermal fibroblasts, stimulating collagen synthesis and inhibiting melanogenesis. This is one of the most evidence-supported topical interventions for photoaging. Oral supplementation provides systemic support; topical application provides local tissue concentrations that oral supplementation cannot achieve.
Wound healing and surgical recovery: Vitamin C requirements increase substantially during wound healing — tissue repair demands increased collagen synthesis, neutrophil activity, and free radical scavenging all simultaneously. Deficiency delays healing and increases complication rates. For post-surgical recovery, burns, or chronic non-healing wounds, supplementation with 1,000–2,000 mg/day is supported by clinical evidence and standard in many surgical and wound care protocols.
Tendon and ligament health: Tendons and ligaments are collagen-dense structures with notoriously poor blood supply and slow healing rates. A 2019 RCT in American Journal of Clinical Nutrition found 15 g vitamin C given 1 hour before brief collagen-stimulating exercise (jump rope) significantly increased serum markers of collagen synthesis (amino-terminal propeptide of type I collagen) compared to placebo. The practical application: a moderate dose (500–1,000 mg) of vitamin C 30–60 minutes before training may enhance connective tissue adaptation to exercise loads.
Optimal Dosing: The Pharmacokinetics Matter
Vitamin C has nonlinear pharmacokinetics. The intestinal transporter (SVCT1) becomes saturated at approximately 200 mg per dose — meaning a 1,000 mg dose is not absorbed five times better than a 200 mg dose. At 200 mg, approximately 90% is absorbed. At 1,250 mg, absorption drops to approximately 50%. For higher doses, spreading intake across multiple smaller doses (200–500 mg with meals) achieves higher steady-state plasma concentrations than single large doses.
Liposomal vitamin C encapsulates ascorbic acid in phospholipid vesicles, bypassing SVCT1 transport and achieving absorption via lymphatic uptake. Studies by Hickey and colleagues found oral liposomal vitamin C achieved plasma concentrations 1.5–2.5× higher than equivalent doses of standard ascorbic acid at the same dose. For individuals targeting plasma optimization (e.g., after surgery, during illness, for cancer support protocols), liposomal vitamin C is meaningfully superior. At standard immune-support doses (500–1,000 mg), regular ascorbic acid divided across meals is adequate and far cheaper.
The tolerable upper intake level (UL) is 2,000 mg/day based on risk of osmotic diarrhea — which occurs when unabsorbed vitamin C reaches the colon. This is a dose-dependent, reversible side effect. Kidney stone risk is often cited as a concern: high-dose vitamin C can increase urinary oxalate, and there is a theoretical concern for calcium oxalate stone formation. Evidence suggests this risk is primarily relevant for people with a personal or family history of calcium oxalate stones — for others, the oxalate increase at doses below 2,000 mg/day is clinically insignificant.
High-Dose IV Vitamin C: The Emerging Evidence
Intravenous vitamin C achieves plasma concentrations (10–20 mM) that are completely inaccessible via oral dosing (maximum ~0.2 mM). At these pharmacological concentrations, ascorbate acts as a pro-oxidant in cancer cells — generating hydrogen peroxide in the tumor microenvironment where iron is preferentially concentrated. Multiple phase I/II trials have found IV vitamin C (25–75 g 2–3 times weekly) tolerable as an adjunct to standard cancer therapy, with some evidence for reduced toxicity, improved quality of life, and potentially enhanced treatment response. Phase III trials are ongoing.
In sepsis, IV vitamin C combined with thiamine and hydrocortisone (the “Marik protocol”) received significant attention after a 2017 retrospective study showed dramatic mortality reduction. Subsequent RCTs have shown mixed results — the CITRIS-ALI trial was neutral, while others showed benefit. The current evidence does not establish IV vitamin C as standard-of-care for sepsis, but research continues and the safety profile at used doses is acceptable.
The Bottom Line
Vitamin C is one of the most evidence-supported and underutilized nutrients in functional medicine. The immune benefits — while real — represent only one dimension of a cofactor required for collagen stability, adrenal function, neurotransmitter synthesis, and epigenetic regulation. The optimal dose for most adults is 500–1,000 mg/day in divided doses, with liposomal forms offering superior plasma levels for specific applications. The RDA of 75–90 mg/day prevents scurvy; it does not optimize the enzymatic pathways that vitamin C mediates throughout the body.
If you frequently get sick despite what feels like reasonable health habits, a comprehensive immune assessment including vitamin C status, vitamin D, zinc, and sleep quality is the appropriate starting point. Call our office at (810) 206-1402 to schedule a consultation.
Frequently Asked Questions
Does vitamin C actually prevent colds?
Not in the general population — regular vitamin C supplementation does not significantly reduce cold incidence for most people (Cochrane review, n=11,306). However, it does reduce cold duration by 8% in adults and 14% in children with regular supplementation, and reduces cold incidence by approximately 50% in people under extreme physical stress (marathon runners, military personnel). For everyday immune support, it shortens colds rather than prevents them.
What is the best form of vitamin C?
For standard supplementation (500-1,000 mg/day), plain ascorbic acid taken with meals (which improves absorption and reduces GI irritation) is adequate and cost-effective. Buffered forms (calcium ascorbate, sodium ascorbate) are easier on the stomach at higher doses and produce the same biological effects. Liposomal vitamin C achieves 1.5-2.5x higher plasma levels than equivalent doses of standard ascorbic acid via lymphatic absorption and is worth the premium cost for individuals targeting high plasma concentrations (post-surgery, during illness, cancer support protocols).
Can you take too much vitamin C?
The tolerable upper limit is 2,000 mg/day based on osmotic diarrhea risk — unabsorbed vitamin C in the colon draws water. This is dose-dependent and reversible. Kidney stone risk from vitamin C is often overstated; the oxalate increase at doses below 2,000 mg/day is clinically insignificant for most people without a stone history. Above 2,000 mg/day, GI side effects are common and stone risk increases for susceptible individuals.
Does vitamin C help with fatigue?
Vitamin C is a cofactor for carnitine biosynthesis — carnitine is required to transport long-chain fatty acids into mitochondria for ATP production. Vitamin C deficiency reduces carnitine synthesis and can contribute to fatigue and reduced exercise capacity via this pathway (distinct from the antioxidant and immune mechanisms). This is part of why fatigue is a recognized early symptom of subclinical vitamin C deficiency. Supplementation at 500-1,000 mg/day restores this pathway in deficient individuals.